Tag - Knight Therapeutics

Developments

Knight expands reimbursement for Titan Pharma’s Probuphine in Canada

Knight Therapeutics (TSX:GUD) reached agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for a letter of intent covering reimbursement of Titan Pharmaceuticals’ (NASDAQ:TTNP) Probuphine, the first...

August 6, 2019

Feature

Knight Therapeutics “to get real” as it builds its commercial operations

By Len Zehr In the more than 30 months since its startup, Knight Therapeutics (TSX:GUD) has shown an uncanny knack for raising equity at increasing valuations, building a portfolio of some 20 innovative products for its...

September 20, 2016

Tag - Knight Therapeutics

Knight expands reimbursement for Titan Pharma’s Probuphine in Canada

Knight Therapeutics “to get real” as it builds its commercial operations

General

More